Prevalence of Subjects at a High or Very High Risk of Gastric Cancer in Japan
1
조회
0
다운로드
1
인용
0
참고문헌
초록
Background/Aims: The presence of Helicobacter pylori (H. pylori ) infection represents a high-risk state of gastric cancer, but the risk is even higher in gastric atrophy. H. pylori stool antigen (HpSA) and serum pepsinogen (PG) tests are useful tools for screening present infection and gastric atrophy, respectively. To determine the prevalence of subjects at a high risk (HpSA＋ or PG＋) or very high risk (PG＋) of gastric cancer in Japan, we applied the two tests to a general population. Methods: The subjects included 311 volunteers. We used Meridian HpSA ELISA for the HpSA test and Pepsinogen RIA Beads for the PG test. PG I at ≤70 μg/L and I/II ratio of ≤3.0 were used as cutoffs for PG-test positivity. Results: Positivity rates in HpSA and PG tests significantly increased with age in those younger than 60 years and in all age groups, respectively. The proportions of HpSA−/PG− and HpSA＋/PG＋ subjects decreased and increased with age, respectively. A small proportion of HpSA−/PG＋ subjects were older than 40 years. The prevalence of subjects who were either HpSA＋ or PG＋ increased with age (＞50% of those older than 40 years). Half of the subjects older than 60 years were PG＋. Conclusions: In Japan, more than 50% of general population aged ≥40 years is at a high risk of gastric cancer, and half of the population aged ≥60 years is at a very high risk.
Abstract
Background/Aims: The presence of Helicobacter pylori (H. pylori ) infection represents a high-risk state of gastric cancer, but the risk is even higher in gastric atrophy. H. pylori stool antigen (HpSA) and serum pepsinogen (PG) tests are useful tools for screening present infection and gastric atrophy, respectively. To determine the prevalence of subjects at a high risk (HpSA＋ or PG＋) or very high risk (PG＋) of gastric cancer in Japan, we applied the two tests to a general population. Methods: The subjects included 311 volunteers. We used Meridian HpSA ELISA for the HpSA test and Pepsinogen RIA Beads for the PG test. PG I at ≤70 μg/L and I/II ratio of ≤3.0 were used as cutoffs for PG-test positivity. Results: Positivity rates in HpSA and PG tests significantly increased with age in those younger than 60 years and in all age groups, respectively. The proportions of HpSA−/PG− and HpSA＋/PG＋ subjects decreased and increased with age, respectively. A small proportion of HpSA−/PG＋ subjects were older than 40 years. The prevalence of subjects who were either HpSA＋ or PG＋ increased with age (＞50% of those older than 40 years). Half of the subjects older than 60 years were PG＋. Conclusions: In Japan, more than 50% of general population aged ≥40 years is at a high risk of gastric cancer, and half of the population aged ≥60 years is at a very high risk.
참고문헌 (15)
- Uemura N, "Helicobacter pylori infection and the development of gastric cancer", N Engl J Med, 345, pp.784~789 (2001)
- Ohata H, "Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer", Int J Cancer, 109, pp.138~143 (2004)
- Ohkura R, "Usefulness of a novel enzyme immunoassay for the detection of Helicobacter pylori in feces", Scand J Gastroenterol, 35, pp.49~53 (2000)
- Oishi Y, "The serum pepsinogen test as a predictor of gastric cancer: the Hisayama Study", Am J Epidemiol, 163, pp.629~637 (2006)
- Correa P, "Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention", Cancer Res, 52, pp.6735~6740 (1992)
- Miki K, "Usefulness of gastric cancer screening using the serum pepsinogen test method", Am J Gastroenterol, 98, pp.735~739 (2003)
- Asaka M, "Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population", Gastroenterology, 102, pp.760~766 (1992)
- Yamagata H, "Impact of Helicobacter pylori infection on gastric cancer incidence in a general Japanese population: the Hisayama study", Arch Intern Med, 160, pp.1962~1968 (2000)
- Asaka M, "Atrophic changes of gastric mucosa are caused by Helicobacter pylori infection rather than aging: studies in asymptomatic Japanese adults", Helicobacte, 1, pp.52~56 (1996)
- Sakaki N, "The influence of Helicobacter pylori infection on the progression of gastric mucosal atrophy and occurrence of gastric cancer", Eur J Gastroenterol Hepatol, 7(1), pp.S59~62 (1995)
- Sakaki N, "Ten-year prospective follow-up study on the relationship between Helicobacter pylori infection and progression of atrophic gastritis, particularly assessed by endoscopic findings", Aliment Pharmacol Ther, 16(2), pp.198~203 (2002)
- Asaka M, "Atrophic gastritis and intestinal metaplasia in Japan: results of a large multicenter study", Helicobacter, 6, pp.294~299 (2001)
- Asaka M, "Relationship between Helicobacter pylori infection, atrophic gastritis and gastric carcinoma in a Japanese population", Eur J Gastroenterol Hepatol, 7(1), pp.S7~10 (1995)
- Hamashima C, "The Japanese guidelines for gastric cancer screening", Jpn J Clin Oncol, 38, pp.259~267 (2008)
- Fukase K, "Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial", Lancet, 372, pp.392~397 (2008)